Press release
Bioengineered Neuronal Organoids are now commercially available from myriamed
BENOs are now commercially available from myriamed
BENOs are now commercially available from myriamed.
Get in touch for details: https://bit.ly/2Di5ELG
myriamed GmbH
Rudolf-Wissell-Str. 28a
37079 Göttingen
Tel.: +49 551 28878-170
Email: info@myriamed.com
Web: www.myriamed.com
myriamed – the drug development accelerator
Separating the pharmacological wheat from the chaff is the primary goal of myriamed. Our proprietary human cell and engineered tissue models allow for the simulation of health and disease in the dish. Our platform technologies find broad applications in early stages of drug discovery and refinement of the most promising therapeutic candidates.
The availability of human cell and tissue models is transforming preclinical drug development. Applications range from early stages of lead discovery to advanced individualized phenotypic screens to shape a promising therapeutic candidate. myriamed offers a broad portfolio of highly standardized services as well as custom-made solutions to accelerate drug development.
At myriamed we focus on heart and skeletal muscle. Our myrCell and myrTissue platforms define wanted and unwanted drug effects in a unique human context. myrScreen combines our expertise in phenotypic drug screens and enables deep phenotyping of drug effects on healthy or diseased human heart and skeletal muscle.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bioengineered Neuronal Organoids are now commercially available from myriamed here
News-ID: 2138869 • Views: …
More Releases from myriamed GmbH
myriamed launches online shop
To deliver the best possible service to our customers, myriamed has launched its own online shop. The shop features various human iPSC derived cell types (myrCell) such as cardiomyocytes, skeletal muscle cells and stroma cells as well as various tissue types (myrTissue) such as cardiac tissue, fibrotic tissue or brain organoids. In addition, you can order our proprietary tissue culture plates (myrPlates) via the shop to cast and culture macroscale…
myriamed is a member of the international 4D Bioprinting network
myriamed has become a member of the ZIM innovation network 4D Bioprinting. The network, which is led by EurA AG supports concrete innovative products and new services in the field of bioprinting for applications in biology, pharmacy, and medicine. Thus, the network promotes the commercialization of the innovative technologies of the network partners by market-oriented R&D projects and establishment of new value chains for biopharmaceuticals and medicine.
Phase 1 of the…
myriamed has joined Science Exchange
Science Exchange, the leading SaaS-enabled marketplace platform for outsourced R&D services, has partnered with myriamed. Visit myriamed’s profile to inquire about our services or request a quote. There are no additional contracts required if you request on Science Exchange and you can order immediately.
Please visit our profile here: http://bit.ly/myriamed_Science_Exchange
About myriamed: myriamed has unique expertise in research and development of human induced pluripotent stem cells (iPSC), including genome edited lines, and…
myriamed is now a member of the Network for Pharma Solutions
We are proud to announce that myriamed is now a member of the Network for Pharma Solutions (NetPhaSol). NetPhaSol is a cooperation network focusing on drug discovery & development. It serves as a platform for research, development and marketing of new products, technologies and services in drug development.
About myriamed: myriamed has unique expertise in research and development of human induced pluripotent stem cells (iPSC), including genome edited lines, and in…
